1. Home
  2. LSF vs SCNX Comparison

LSF vs SCNX Comparison

Compare LSF & SCNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Laird Superfood Inc.

LSF

Laird Superfood Inc.

HOLD

Current Price

$3.34

Market Cap

23.8M

ML Signal

HOLD

Logo Scienture Holdings Inc.

SCNX

Scienture Holdings Inc.

HOLD

Current Price

$0.49

Market Cap

24.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LSF
SCNX
Founded
2015
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Packaged Foods
Other Pharmaceuticals
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
23.8M
24.8M
IPO Year
2020
2020

Fundamental Metrics

Financial Performance
Metric
LSF
SCNX
Price
$3.34
$0.49
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$12.00
N/A
AVG Volume (30 Days)
124.1K
1.5M
Earning Date
02-25-2026
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$48,146,862.00
$653,391.00
Revenue This Year
$18.05
N/A
Revenue Next Year
$17.53
N/A
P/E Ratio
N/A
N/A
Revenue Growth
17.73
207.88
52 Week Low
$1.98
$0.46
52 Week High
$8.26
$4.13

Technical Indicators

Market Signals
Indicator
LSF
SCNX
Relative Strength Index (RSI) 61.78 42.86
Support Level $3.07 $0.47
Resistance Level $3.62 $0.51
Average True Range (ATR) 0.33 0.04
MACD 0.07 0.00
Stochastic Oscillator 73.88 23.36

Price Performance

Historical Comparison
LSF
SCNX

About LSF Laird Superfood Inc.

Laird Superfood Inc is engaged in the business of manufacturing and marketing differentiated plant-based and functional foods. The product portfolio includes Coffee creamers, Hydration products and beverage-enhancing supplements, Harvest snacks and various other food items, and Coffee, tea, and hot chocolate products.

About SCNX Scienture Holdings Inc.

Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs and optimize the prescription journey and patient engagement in the U.S.

Share on Social Networks: